platinum has been researched along with naproxen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CF; Chen, TY; Chin, CJ; Kuo, YT; Lee, M; Liu, YT | 1 |
| Chang, C; Chen, Y; Han, J; Hua, X; Li, D; Li, L; Li, Z; Liu, Z; Wang, Q; Wang, Z | 1 |
| Eichhorn, T; Hey-Hawkins, E; Kaluđerović, GN; Morgan, I; Predarska, I; Saoud, M | 1 |
3 other study(ies) available for platinum and naproxen
| Article | Year |
|---|---|
Effective anodic oxidation of naproxen by platinum nanoparticles coated FTO glass.
Topics: Electrochemistry; Electrodes; Fluorine; Humic Substances; Kinetics; Naproxen; Oxidation-Reduction; Platinum; Tin Compounds; Water Pollutants, Chemical; Water Purification | 2014 |
Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Inflammation; Mice; Nanoparticles; Naproxen; Platinum; Serum Albumin, Bovine | 2021 |
Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Humans; Ibuprofen; Molecular Structure; Naproxen; Platinum; Silicon Dioxide | 2022 |